Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.01)
# 2,981
Out of 4,888 analysts
209
Total ratings
25.94%
Success rate
-1.26%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.38 | +552.17% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.65 | +1,124.74% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $6.20 | +206.45% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.48 | +61.29% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.20 | -9.09% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.56 | +1,336.78% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.37 | +463.80% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.12 | +890.61% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $2.57 | +483.66% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $1.18 | +4,645.76% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.32 | +657.58% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.50 | +297.69% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $20.59 | +45.70% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.06 | +169.31% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.66 | +52,930.30% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.41 | +369.21% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.94 | +539.80% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.83 | +5,364.48% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.03 | +1,647.57% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.38 | +742.11% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $9.18 | +171,468.63% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $12.17 | +4,008.46% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $16.88 | +1,321.80% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.91 | +8,681.56% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.80 | +12,375.05% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.78 | +138,250.86% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.46 | +379.45% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.32 | +1,193.10% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.35 | +1,605.76% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $2.65 | +579.25% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.16 | +131.48% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $7.51 | +19,074.43% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $36.58 | -34.39% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $2.13 | +160,463.38% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $2.09 | +908,990.91% | 1 | Oct 6, 2017 | |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.38
Upside: +552.17%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.65
Upside: +1,124.74%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $6.20
Upside: +206.45%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.48
Upside: +61.29%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.20
Upside: -9.09%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.56
Upside: +1,336.78%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.37
Upside: +463.80%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.12
Upside: +890.61%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $2.57
Upside: +483.66%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $1.18
Upside: +4,645.76%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.32
Upside: +657.58%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.50
Upside: +297.69%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $20.59
Upside: +45.70%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.06
Upside: +169.31%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.66
Upside: +52,930.30%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.41
Upside: +369.21%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.94
Upside: +539.80%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.83
Upside: +5,364.48%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.03
Upside: +1,647.57%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.38
Upside: +742.11%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $9.18
Upside: +171,468.63%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $12.17
Upside: +4,008.46%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $16.88
Upside: +1,321.80%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.91
Upside: +8,681.56%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.80
Upside: +12,375.05%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.78
Upside: +138,250.86%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.46
Upside: +379.45%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.32
Upside: +1,193.10%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.35
Upside: +1,605.76%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $2.65
Upside: +579.25%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.16
Upside: +131.48%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $7.51
Upside: +19,074.43%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $36.58
Upside: -34.39%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $2.13
Upside: +160,463.38%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $2.09
Upside: +908,990.91%